Notably, a study on Myc-induced lymphoma demonstrated that inhibiting autophagy, either through chloroquine or ATG5 shRNA, augmented the impact of p53 activation and alkylating drug therapies, leading to enhanced tumor cell apoptosis. This evidence concerns the gene TP53 and lymphoma.